世卫组织通报发现猴痘病毒重组毒株病例：两名患者感染

Core Viewpoint - The World Health Organization (WHO) reported cases of a new monkeypox virus strain resulting from the recombination of branch Ib and branch IIb strains, but the overall risk for the general population without specific risk factors remains "low" [1] Group 1: Virus Recombination and Cases - Recent reports indicate two patients infected with a new strain of monkeypox virus, which is a result of recombination between branch Ib and branch IIb [1] - The first case was reported in the UK, with a travel history to Southeast Asia, while the second case was found in India, with travel history to the Arabian Peninsula [1] - Genetic analysis shows that both patients were infected with the same recombinant strain, suggesting that the actual number of cases may be higher than currently reported [1] Group 2: Clinical Presentation and Risk Assessment - Both reported cases did not exhibit severe symptoms, and their clinical presentation was similar to that observed in infections with other monkeypox virus branches [1] - Contact tracing for both cases has been completed, with no secondary cases identified [1] - The WHO maintains its overall public health risk assessment for monkeypox as "low" for the general population without specific risk factors [1] Group 3: Monkeypox Overview - Monkeypox is an infectious disease caused by the monkeypox virus, primarily transmitted through close contact with infected individuals [1] - Symptoms include painful rashes, lymphadenopathy, fever, headache, and myalgia [1] - The monkeypox virus has two main branches, I and II, which further evolve into variants Ia, Ib, IIa, and IIb [1]